Impact of time-varying center volume on technique failure and mortality in peritoneal dialysis.


Journal

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
ISSN: 1718-4304
Titre abrégé: Perit Dial Int
Pays: United States
ID NLM: 8904033

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 31 7 2020
medline: 11 1 2022
entrez: 31 7 2020
Statut: ppublish

Résumé

Most studies on volume-outcome association used the number of patients at a particular period as the independent variable. However, peritoneal dialysis (PD) is a chronic treatment, and center volume usually changes over a patient's treatment period. Accordingly, this study used the time-varying center volume to explore the volume-outcome association in PD. We conducted a nationwide population-based retrospective cohort study, which included patients who began chronic PD between 2001 and 2010. The risk factors of 5-year technique failure and mortality were analyzed using cause-specific and subdistribution hazard models, respectively. The annual number of patients initiating PD in each patient's treatment center was modeled as a time-varying variable with four categories. We included 9071 patients who started PD in 100 centers where the number of incident patients ranged from 1 to 107 patients per year (median, 25; interquartile range, 13-42). The estimated 5-year patient and technique survival rates were 64.7% and 66.6%, respectively. Being treated in centers in the largest volume category (the number of incident PD patients ≥43 per year) was associated with significantly lower cause-specific and cumulative hazards for technique failure. No association was found between facility volume and hazards of mortality. Receiving PD in high-volume facilities was associated with a lower risk in technique failure. No association was found between facility volume and mortality risk.

Sections du résumé

BACKGROUND
Most studies on volume-outcome association used the number of patients at a particular period as the independent variable. However, peritoneal dialysis (PD) is a chronic treatment, and center volume usually changes over a patient's treatment period. Accordingly, this study used the time-varying center volume to explore the volume-outcome association in PD.
METHODS
We conducted a nationwide population-based retrospective cohort study, which included patients who began chronic PD between 2001 and 2010. The risk factors of 5-year technique failure and mortality were analyzed using cause-specific and subdistribution hazard models, respectively. The annual number of patients initiating PD in each patient's treatment center was modeled as a time-varying variable with four categories.
RESULTS
We included 9071 patients who started PD in 100 centers where the number of incident patients ranged from 1 to 107 patients per year (median, 25; interquartile range, 13-42). The estimated 5-year patient and technique survival rates were 64.7% and 66.6%, respectively. Being treated in centers in the largest volume category (the number of incident PD patients ≥43 per year) was associated with significantly lower cause-specific and cumulative hazards for technique failure. No association was found between facility volume and hazards of mortality.
CONCLUSIONS
Receiving PD in high-volume facilities was associated with a lower risk in technique failure. No association was found between facility volume and mortality risk.

Identifiants

pubmed: 32729780
doi: 10.1177/0896860820940449
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

569-577

Auteurs

Yen-Hung Yao (YH)

Division of Nephrology, Department of Medicine, 218818National Yang-Ming University Hospital, Yilan.
Institute of Public Health, School of Medicine, 34882National Yang-Ming University, Taipei.

Chyong-Mei Chen (CM)

Institute of Public Health, School of Medicine, 34882National Yang-Ming University, Taipei.

Yiing-Jenq Chou (YJ)

Institute of Public Health, School of Medicine, 34882National Yang-Ming University, Taipei.

Nicole Huang (N)

Institute of Hospital and Health Administration, School of Medicine, 34882National Yang-Ming University, Taipei.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH